News
MyChesCo on MSN13h
Palvella Therapeutics Showcases Progress on QTORIN Rapamycin Gel for Rare Genetic DisorderWAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) announced the presentation of its investigational therapy QTORIN™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback